Blood thinners are essential medications that help prevent uncontrolled blood clotting. Blood clots can lead to serious health risks such as strokes, heart attacks, and pulmonary embolisms. In the United States, over eight million people rely on these medications to manage their risk of developing harmful blood clots, making them a critical component of many patients’ treatment plans.
A diverse array of blood thinner medications are available, including well-known options like Eliquis (apixaban), Warfarin, and Xarelto (rivaroxaban). Some drugs have been around for years and have long established efficacy while there are newer options that offer lesser side effects. Each has its mechanism of action, dosing requirements, and potential side effects.
In this article, we will provide a comprehensive blood thinner medications list and explore their costs, benefits, potential side effects, and more.
What are the different types of blood thinners?
Anticoagulants
Anticoagulants prevent blood clots by interfering with the body’s natural clotting process. They target specific proteins involved in coagulation, lowering the risk of serious complications such as heart attacks and strokes. Often prescribed for conditions like atrial fibrillation and deep vein thrombosis, these medications may require regular blood tests to monitor their effectiveness.
Below are the different types of anticoagulants:
-
- Vitamin K Antagonists
- Direct Factor Xa Inhibitors
- Direct Thrombin Inhibitors
- Unfractionated Heparin
- Low Molecular Weight Heparins
- Fondaparinux
Antiplatelet Agents
Antiplatelet medicines prevent platelets from sticking together to form clots. This is especially essential in preventing arterial blockages, which can lead to a heart attack or stroke. These drugs, which aids in keeping the blood flowing normally, are administered to individuals with heart problems.
What are the most common blood thinners?
Here is the blood thinner medication list with their cost, dosage, side effects, and other information:
Price: Starts at $157 (for 60 tabs of 2.5 mg)
Active ingredients: Apixaban
Drug class: Anticoagulant (Factor Xa inhibitor)
Dosage form: 2.5 mg and 5 mg tablets
Dosage frequency: Twice daily
Approved indications:
- Reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
- Prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients after hip or knee replacement surgery.
- Treatment of DVT and PE and reducing the risk of recurrence after initial therapy.
Common side effects: Bleeding
Pros:
Cons:
Price: Starts at $84.95 (for 10 prefilled syringes of 0.2 ml)
Active ingredients: Dalteparin
Drug class: Anticoagulant (Heparin)
Dosage form: Single dose prefilled syringe
Dosage frequency: Once or twice daily injection, depending on the condition.
Approved indications:
- Ischemic complications of unstable angina and non-Q-wave myocardial infarction in adults
- DVT prevention in abdominal surgery, hip replacement, or patients with restricted mobility during acute illness in adults
- Reduce recurrence of symptomatic VTE for adult patients with cancer and pediatric patients (from birth, ?35 weeks gestational age)
Common side effects: Bleeding (including hemorrhage), thrombocytopenia (low number of platelets), hematoma and pain at the injection site, and transient elevation of transaminase (liver enzymes).
Pros:
Cons:
Price: Starts at $84.95 (for 10 prefilled syringes of 0.3 ml)
Active ingredients: Enoxaparin sodium
Drug class: Anticoagulant (Low molecular weight heparin)
Dosage form: Single dose prefilled syringe
Dosage frequency: Once or twice daily injection, depending on the condition.
Approved indications:
- DVT prevention in abdominal surgery, hip replacement, knee replacement, or patients with limited mobility due to acute illness.
- Acute DVT treatment with or without pulmonary embolism.
- Prevention of ischemic complications of unstable angina and non–Q-wave myocardial infarction (MI).
- Treatment of acute ST-segment elevation myocardial infarction (STEMI), whether managed medically or with percutaneous coronary intervention.
Common side effects: Bleeding, anemia, thrombocytopenia, elevation of serum aminotransferase (liver enzymes), diarrhea, nausea, bruising, fever, edema, dyspnea, confusion, and injection site pain.
Pros:
Pros:

Price: Starts at $69.99 (for 28 tabs of 7.5 mg)
Active ingredients: Clopidogrel
Drug class: Antiplatelet (P2Y12 platelet inhibitor)
Dosage form: 75 mg, 300 mg tablets
Dosage frequency: Once daily
Approved indications:
- Acute coronary syndrome (ACS):
- Non-ST-segment elevation ACS (like unstable angina or non-ST-elevation myocardial infarction).
- Reduces the risk of cardiovascular death, heart attack (MI), stroke, or worsening chest pain.
- ST-segment elevation myocardial infarction (STEMI):
- Lowers the risk of death from any cause and decreases chances of death, repeat heart attack, or stroke.
- Reduces the risk of new stroke, new heart attack, or death from blood vessel-related issues
Common side effects: Bleeding
Pros:
Cons:
Price: Starts at $120.00 (for 30 capsules of 75 mg)
Active ingredients: Dabigatran
Drug class: Anticoagulant (Direct thrombin inhibitor)
Dosage form: 75 mg, 110 mg and 150 mg capsules
Dosage frequency: Twice daily
Approved indications:
- Stroke and systemic embolism prevention in adults with non-valvular atrial fibrillation.
- Treatment of DVT and PE in adults after 5-10 days of parenteral anticoagulant.
- Reduction of DVT and PE recurrence risk in previously treated adults.
- DVT and PE prophylaxis post-hip replacement in adults.
- VTE treatment in pediatric patients (8-18 years) after 5 days of parenteral anticoagulant.
- Reduction of VTE recurrence risk in previously treated pediatric patients (8-18 years).
Common side effects: Bleeding and gastrointestinal side effects
Pros:
Cons:
Helpful Article
Learn more about Pradaxa and how it compares to another anticoagulant, Eliquis, in this comparison guide on Eliquis vs Pradaxa.
Price: Starts at $77.99 (for 30 tabs of 10 mg)
Active ingredients: Prasugrel
Drug class: Antiplatelet (P2Y platelet inhibitor)
Dosage form: 5 mg and 10 mg tablets
Dosage frequency: Once daily
Approved indications:
- For UA or NSTEMI patients managed with PCI or stents
- For STEMI patients managed with primary or delayed PCI
- Reduces risk of heart attack, stroke, and cardiovascular death in PCI-treated ACS patients.
- Used with aspirin to prevent clots in ACS patients post-PCI
Common side effects: bleeding, body pains, dizziness, fatigue, and allergic reactions such as rash and hives.
Pros:
Cons:
Price: Starts at $36.99 (for 100 tabs of 1 mg)
Active ingredients: Warfarin
Drug class: Anticoagulant (Vitamin K antagonist)
Dosage form: 1 mg, 2 mg, 2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg, and 10 mg tablets
Dosage frequency: Once daily
Approved indications:
- Prevention and treatment of DVT
- Prevention and treatment of PE
- Reduce the risk of death and recurrent MI
- Reduce the risk of thromboembolic events such as stroke or systemic embolization after MI
Common side effects: Bleeding and gastrointestinal side effects
Pros:
Cons:
Helpful Article
How does the long-established Warfarin compare to the newer blood thinner, Eliquis? Find out in our detailed guide on Eliquis vs Warfarin.
Price: Starts at $199 (for 100 tabs of 2.5 mg)
Active ingredients: Rivaroxaban
Drug class: Anticoagulant (Factor Xa inhibitor)
Dosage form: 2.5 mg, 10 mg, 15 mg, and 20 mg tablets
Dosage frequency: Once or twice daily, depending on the condition
Approved indications:
- Reduce risk of stroke and systemic embolism in nonvalvular atrial fibrillation
- Treatment of DVT
- Treatment of PE
- Reduction in the risk of recurrence of DVT or PE
- Prevention of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery
- Prevention of VTE in acutely ill medical patients
- Reduce the risk of major cardiovascular events in patients with CAD
- Reduce the risk of major thrombotic vascular events in patients with peripheral artery disease (PAD), including patients after recent lower extremity revascularization due to symptomatic PAD
- Treatment of VTE and reduction in the risk of recurrent VTE in pediatric patients from birth to less than 18 years
- For thromboprophylaxis in pediatric patients 2 years and older with congenital heart disease after the Fontan procedure
Common side effects: Bleeding, cough, vomiting, and gastroenteritis.
Pros:
Cons:
Final Thoughts
Blood thinner medications are essential in treating serious complications in patients with various cardiovascular and thromboembolic disorders. However, anticoagulants and antiplatelet drugs are not all the same, so careful consideration is needed when selecting the right treatment. It’s important to consider factors like cost, side effects, and whether a specific medication truly fits a condition. Talking with a healthcare provider can help find the option that best suits a patient’s health needs.
Frequently Asked Questions
Sources
Stop the Clot. (n.d.). Living your best life while taking blood thinners. Retrieved from https://www.stoptheclot.org/living-your-best-life-while-taking-blood-thinners/
MedlinePlus. (n.d.). Blood thinners. Retrieved from https://medlineplus.gov/bloodthinners.html
U.S. Food and Drug Administration. (2012). Plavix (clopidogrel) tablets prescribing information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202155s000lbl.pdf
Pfizer. (n.d.). Lovenox (enoxaparin sodium) prescribing information. Retrieved from https://labeling.pfizer.com/showlabeling.aspx?id=2293
Sanofi. (n.d.). Lovenox prescribing information. Retrieved from https://products.sanofi.us/lovenox/lovenox.pdf
U.S. Food and Drug Administration. (2010). Lovenox (enoxaparin sodium) prescribing information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020839s048lbl.pdf
Boehringer Ingelheim. (n.d.). Pradaxa capsules prescribing information. Retrieved from https://content.boehringer-ingelheim.com/DAM/c669f898-0c4e-45a2-ba55-af1e011fdf63/pradaxa%20capsules-us-pi.pdf
U.S. Food and Drug Administration. (2011). Pradaxa (dabigatran etexilate mesylate) prescribing information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022307s003lbl.pdf
MedlinePlus. (n.d.). Drug information: Prasugrel. Retrieved from https://medlineplus.gov/druginfo/meds/a682277.html
U.S. Food and Drug Administration. (2011). Effient (prasugrel) tablets prescribing information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/009218s107lbl.pdf
Janssen Pharmaceuticals. (n.d.). Xarelto (rivaroxaban) prescribing information. Retrieved from https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/XARELTO-pi.pdf
National Center for Biotechnology Information. (n.d.). National Institutes of Health. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK507910/
American Heart Association. (2022). Practice guidelines for anticoagulation in patients with atrial fibrillation. Retrieved from https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.122.062770
National Center for Biotechnology Information. (2021). PMCID: PMC7901998. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC7901998/
National Center for Biotechnology Information. (2009). PMCID: PMC2650665. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC2650665/
National Health Service. (n.d.). Common questions about warfarin. Retrieved from https://www.nhs.uk/medicines/warfarin/common-questions-about-warfarin/
New England Journal of Medicine. (2010). A comparison of rivaroxaban and warfarin in patients with atrial fibrillation. Retrieved from https://www.nejm.org/doi/full/10.1056/NEJMoa1009638
MedlinePlus. (n.d.). Drug information: Dabigatran from https://medlineplus.gov/druginfo/meds/a682159.html
Medical News Today. (2019). Ginger as a natural blood thinner. Retrieved from https://www.medicalnewstoday.com/articles/322384#ginger
Kaiser Permanente. (n.d.). Blood thinners to avoid prior to surgery. Retrieved from https://mydoctor.kaiserpermanente.org/ncal/article/blood-thinners-to-avoid-prior-to-surgery-san-rafael-medical-center-ophthalmology-191550
Cleveland Clinic. (n.d.). Anticoagulants: What you need to know. Retrieved from https://my.clevelandclinic.org/health/treatments/22288-anticoagulants
Mayo Clinic. (2022). Warfarin: What to know about this anticoagulant. Retrieved from https://www.mayoclinic.org/diseases-conditions/thrombophlebitis/expert-answers/warfarin/faq-20058443
Stop the Clot. (n.d.). Managing anticoagulants. Retrieved from https://www.stoptheclot.org/about-clots/managing-anticoagulants/
National Center for Biotechnology Information. (2015). Dalteparin (Fragmin). In Safer Use of Medications (pp. 1-5). https://www.ncbi.nlm.nih.gov/books/NBK279433/
Sweeney, M. M., & Goehring, A. O. (2005). Anticoagulant therapy in the outpatient setting: A review of the evidence. American Family Physician, 71(9), 1802-1814. https://www.aafp.org/pubs/afp/issues/2005/0501/p1802.html











